| September 29, 2020 Edition COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics. | | Researchers designed "miniproteins" that bound tightly to the SARS-CoV-2 spike protein and prevented the virus from infecting human cells in the lab. | | Researchers found that diabetic foot ulcers don't recruit the immune cells necessary for normal wound healing. The study also identified potential targets for future therapies. | | Scientists identified how anesthetic and benzodiazepine drugs change a brain receptor's shape. The findings suggest ways to design more tailored anesthetic drugs. | | | |
No comments:
Post a Comment